Kovács András, Patai Zoltán, Guttman András, Kádas János, Takács László, Kurucz István
Horváth Laboratory of Bioseparation Sciences, Research Centre for Molecular Medicine, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary.
Electrophoresis. 2013 Nov;34(20-21):3064-71. doi: 10.1002/elps.201200677.
Immunization with complex mixtures, like the human plasma resulted in the generation of cloned mAb libraries (PlasmaScan™ and QuantiPlasma™ libraries, with >1000 individual mAbs) reacting with a nonredundant set of antigenic epitopes. mAb proteomics refers to quasi-hypothesis-free profiling of plasma samples with nascent or cloned mAb libraries for the discovery of disease-specific biomarkers. Once mAbs with biomarker potential have been identified, the next task is the determination of cognate antigens recognized by the respective mAbs. To determine the cognate protein antigen corresponding to each individual mAbs in the cloned mAb libraries, we have separated human plasma by consecutive steps of desalting and various chromatography procedures. The process resulted in 783 fractions, which we termed "Analyte Library" (AL). The AL represents the human plasma proteome in relatively low-protein complexity fractions. Here, to determine the utility of the AL, we selected ten plasma proteins and checked for their presence in the fractions. Among the ten cases, the distribution of four selected plasma proteins matched expectations, as these proteins were present only in a few fractions corresponding to their physical, chemical, and biochemical properties. However, in six cases, we observed "smear" -like distribution or complete absence of the proteins, suggesting that protein-protein interactions or protein variants may alter the observed plasma distribution profiles. Nevertheless, we conclude that the AL is an efficient, high throughput tool to complement the mAb biomarker discovery process with cognate protein antigen identification for each mAbs.
用复杂混合物(如人血浆)进行免疫可产生克隆的单克隆抗体库(PlasmaScan™和QuantiPlasma™库,含超过1000种个体单克隆抗体),这些库与一组非冗余的抗原表位发生反应。单克隆抗体蛋白质组学是指利用新生或克隆的单克隆抗体库对血浆样本进行近乎无假设的分析,以发现疾病特异性生物标志物。一旦鉴定出具有生物标志物潜力的单克隆抗体,接下来的任务就是确定各个单克隆抗体所识别的同源抗原。为了确定克隆的单克隆抗体库中每个单克隆抗体对应的同源蛋白质抗原,我们通过连续的脱盐步骤和各种色谱程序对人血浆进行了分离。该过程产生了783个组分,我们将其称为“分析物库”(AL)。AL以相对低蛋白复杂性的组分形式代表了人血浆蛋白质组。在此,为了确定AL的效用,我们选择了十种血浆蛋白并检查它们在这些组分中的存在情况。在这十个案例中,四种选定血浆蛋白的分布符合预期,因为这些蛋白仅存在于与其物理、化学和生化性质相对应的少数几个组分中。然而,在六个案例中,我们观察到了“拖尾”样分布或蛋白质完全缺失的情况,这表明蛋白质-蛋白质相互作用或蛋白质变体可能会改变观察到的血浆分布谱。尽管如此,我们得出结论,AL是一种高效的高通量工具,可通过为每个单克隆抗体鉴定同源蛋白质抗原,来补充单克隆抗体生物标志物的发现过程。